Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.

Cytosine residues at CpG dinucleotides can be methylated by endogenous methyltransferases in mammalian cells. The resulting 5-methylcytosine base may undergo spontaneous deamination to form thymine causing G/C to A/T transition mutations. Methylated CpGs also can form preferential targets for environmental mutagens and carcinogens. The Big Blue(R) transgenic mouse has been used to investigate tissue and organ specificity of mutations and to deduce mutational mechanisms in a mammal in vivo. The transgenic mouse contains approximately 40 concatenated lambda-like shuttle vectors, each of which contains one copy of an Escherichia coli lacI gene as a mutational target. lacI mutations in lambda transgenic mice are characterized by a high frequency of spontaneous mutations targeted to CpG dinucleotides suggesting an important contribution from methylation-mediated events. To study the methylation status of CpGs in the lacI gene, we have mapped the distribution of 5-methylcytosines along the DNA-binding domain and flanking sequences of the lacI gene of transgenic mice. We analyzed genomic DNA from various tissues including thymus, liver, testis, and DNA derived from two thymic lymphomas. The mouse genomic DNAs and methylated and unmethylated control DNAs were chemically cleaved, then the positions of 5-methylcytosines were mapped by ligation-mediated PCR which can be used to distinguish methylated from unmethylated cytosines. Our data show that most CpG dinucleotides in the DNA binding domain of the lacI gene are methylated to a high extent (>98%) in all tissues tested; only a few sites are partially (70-90%) methylated. We conclude that tissue-specific methylation is unlikely to contribute significantly to tissue-specific mutational patterns, and that the occurrence of common mutation sites at specific CpGs in the lacI gene is not related to selective methylation of only these sequences. The data confirm previous suggestions that the high frequency of CpG mutations in lacI transgenes is related to the presence of 5-methylcytosine bases.

[1]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Tang,et al.  Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.

[3]  Jeffrey H. Miller,et al.  Mutagenic deamination of cytosine residues in DNA , 1980, Nature.

[4]  G. Pfeifer,et al.  Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. , 1997, Cancer research.

[5]  J. Vijg,et al.  Transgenic mice as model systems for studying gene mutations in vivo. , 1993, Trends in genetics : TIG.

[6]  S. Tornaletti,et al.  Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. , 1995, Oncogene.

[7]  J. Short,et al.  Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen. , 1994, Mutation research.

[8]  S. Tapscott,et al.  De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Z. Siegfried,et al.  Spl elements protect a CpG island from de novo methylation , 1994, Nature.

[10]  B. Wold,et al.  Genomic sequencing and methylation analysis by ligation mediated PCR. , 1989, Science.

[11]  G. Douglas,et al.  Analysis of tissue-specific lacZ mutations induced by N-nitrosodibenzylamine in transgenic mice. , 1997, Carcinogenesis.

[12]  K. Tindall,et al.  Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice , 1997, Environmental and molecular mutagenesis.

[13]  A. Bird,et al.  High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines , 1990, Cell.

[14]  T. Skopek,et al.  Effect of target gene CpG content on spontaneous mutation in299 transgenic mice. , 1998, Mutation research.

[15]  G. Pfeifer,et al.  Mouse DNA‐cytosine‐5‐methyltransferase: sequence specificity of the methylation reaction and electron microscopy of enzyme‐DNA complexes. , 1985, The EMBO journal.

[16]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[17]  S. Sommer,et al.  The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene. , 1994, American journal of human genetics.

[18]  A. Furano,et al.  The left end of rat L1 (L1Rn, long interspersed repeated) DNA which is a CpG island can function as a promoter. , 1988, Nucleic acids research.

[19]  A. Riggs,et al.  DNA methylation and gene function. , 1980, Science.

[20]  S. Cross,et al.  CpG islands and genes. , 1995, Current opinion in genetics & development.

[21]  Robert L. Tanguay,et al.  In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. , 1990, Genes & development.

[22]  B. Glickman,et al.  The Use of lacI Transgenic Mice in Genetic Toxicology , 1996 .

[23]  M. Azim Surani,et al.  Parental-origin-specific epigenetic modification of the mouse H19 gene , 1993, Nature.

[24]  J. Ashby,et al.  Use of transgenic mouse lacI/Z mutation assays in genetic toxicology. , 1994, Mutagenesis.

[25]  J. Haavik,et al.  Spontaneous mutation frequencies and spectra in p53 (+/+) and p53 (-/-) mice: a test of the 'guardian of the genome' hypothesis in the Big Blue transgenic mouse mutation detection system. , 1997, Mutation research.

[26]  A. Bird,et al.  Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. , 1994, Genes & development.

[27]  B. Glickman,et al.  Development of a lambda-based complementation assay for the preliminary localization of lacI mutants from the Big Blue mouse: implications for a DNA-sequencing strategy. , 1994, Mutation research.

[28]  A. Riggs,et al.  Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Schaaper,et al.  Mechanisms of spontaneous mutagenesis: an analysis of the spectrum of spontaneous mutation in the Escherichia coli lacI gene. , 1986, Journal of molecular biology.

[30]  T. Skopek,et al.  System Issues: Mutagenic response of the endogenous hprt gene and lacl transgene in benzo[a]pyrene‐treated Big Blue™ B6C3F1 mice , 1996 .

[31]  J. Short,et al.  Characterization of mutations induced by ethylnitrosourea in seminiferous tubule germ cells of transgenic B6C3F1 mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Walsh,et al.  Cytosine methylation and the ecology of intragenomic parasites. , 1997, Trends in genetics : TIG.

[33]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[34]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[35]  J. Jiricny,et al.  Cloning and Expression of Human G/T Mismatch-specific Thymine-DNA Glycosylase* , 1996, The Journal of Biological Chemistry.

[36]  S. Tornaletti,et al.  Ligation-Mediated PCR for Analysis of UV Damage , 1996 .

[37]  R. Drouin,et al.  UVB‐induced Cyclobutane Pyrimidine Dimer Frequency Correlates with Skin Cancer Mutational Hotspots in p53 , 1997, Photochemistry and photobiology.

[38]  S. S. Smith,et al.  RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferase. , 1988, Nucleic acids research.

[39]  A. Riggs,et al.  Analysis of methylation and chromatin structure. , 1993, Methods in enzymology.

[40]  S. Sommer,et al.  Fluorescence in situ hybridization for rapid differentiation of zygosity in transgenic mice. , 1995, BioTechniques.

[41]  M. Tang,et al.  Cytosine methylation determines hot spots of DNA damage in the human P53 gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Pfeifer,et al.  Mapping of UV photoproducts within ras proto-oncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. , 1992, Oncogene.

[43]  D L Putman,et al.  Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Jones,et al.  DNA methylation errors and cancer. , 1996, Cancer research.

[45]  D. Schaid,et al.  System issues: Spontaneous mutation in Big Blue® transgenic mice: Analysis of age, gender, and tissue type , 1996 .

[46]  M. Tang,et al.  Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. , 1998, Cancer research.

[47]  J. Haavik,et al.  p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. , 1995, Oncogene.

[48]  C. Harris,et al.  p53: at the crossroads of molecular carcinogenesis and risk assessment. , 1993, Science.